ConductScience.org, home

Paper4580141

[Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives].

Nocke-Finck L and 2 others. Dtsch Med Wochenschr, 1973. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. [Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives]. Papers, record 4580141. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4580141

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives].
PubMed
Journal
Dtsch Med Wochenschr
PubMed
Year
1973
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
4.17
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nocke-Finck LL
2Breuer HH
3Reimers DD

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Contraceptives, OralMajor topic
EstrogensMajor topic
Menstruation DisturbancesMajor topic
RifampinMajor topic
Adolescent
Adult
Clinical Trials as Topic
Estriol
Estrone
Ethambutol
Ethinyl Estradiol
Female
Humans
Isoniazid
Pregnancy
Streptomycin
Tuberculosis, Pulmonary

Source PubMed

Download CSV of topics

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
39106314U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.MMWR Recomm Rep2024https://conductscience.org/library/papers/39106314PubMed
32837681A history of the roles of cytochrome P450 enzymes in the toxicity of drugs.Toxicol Res2021https://conductscience.org/library/papers/32837681PubMed
8347289Oral contraceptives. Are drug interactions of clinical significance?Drug Saf1993https://conductscience.org/library/papers/8347289PubMed
7698081Interactions between clinically used drugs and oral contraceptives.Environ Health Perspect1994https://conductscience.org/library/papers/7698081PubMed
7397060Acute cardiac failure during treatment with digitoxin--an interaction with rifampicin.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7397060PubMed
7009137Interindividual variation and drug interactions with hormonal steroid contraceptives.Drugs1981https://conductscience.org/library/papers/7009137PubMed
6995091Adverse antibiotic drug interactions.Drugs1980https://conductscience.org/library/papers/6995091PubMed
6424759Interaction between oral contraceptives and griseofulvin.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6424759PubMed
6342899Clinical pharmacokinetics of oral contraceptive steroids.Clin Pharmacokinet1983https://conductscience.org/library/papers/6342899PubMed
6113907Clinical implications of enzyme induction and enzyme inhibition.Clin Pharmacokinet1981https://conductscience.org/library/papers/6113907PubMed
4074601Influence of rifampicin and isoniazid on the kinetics of phenytoin.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4074601PubMed
4073960[Drug interactions in the use of steroid hormones, especially oral contraceptives].Arch Gynecol1985https://conductscience.org/library/papers/4073960PubMed
3453828A case of variant angina exacerbated by administration of rifampicin.Heart Vessels1987https://conductscience.org/library/papers/3453828PubMed
3048976Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.Drugs1988https://conductscience.org/library/papers/3048976PubMed
1559307Pharmacokinetic drug interactions with rifampicin.Clin Pharmacokinet1992https://conductscience.org/library/papers/1559307PubMed
1264830Serologic studies on the occurrence of specific rifampicin antibodies during continuous rifampicin treatment--its frequency and significance.Pneumonologie1976https://conductscience.org/library/papers/1264830PubMed
1233266Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/1233266PubMed
1233229Effect of rifampicin treatment on the metabolism of oestradiol and 17alpha-ethinyloestradiol by human liver microsomes.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/1233229PubMed
1001220Drug stimulated biotransformation of hormonal steroid contraceptives: clinical implications.Drugs1976https://conductscience.org/library/papers/1001220PubMed
346286Clinical pharmacokinetics of rifampicin.Clin Pharmacokinet1978https://conductscience.org/library/papers/346286PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4580141

GET https://conductscience.org/api/papers/v1/4580141/cited_by?page=2